Evaluating the Occurrence of DKA in People With Type I Diabetes

Sponsor
Abbott Diabetes Care
Study ID
NCT07739342
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
2 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Abbott Continuous Dual Glucose Ketone Monitoring System — DEVICE
    Participant will utilize the Abbott Continuous Dual Glucose Ketone Monitoring System in place of the Standard of Care

Study Details

This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.

Key Dates

First listed
Jul 31, 2026
Start date
Sep 30, 2026
Status verified
Jul 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
1,200 participants (estimated)

Arms

  • Arm: Type I Diabetic patients using a Continuous Dual Glucose Ketone Sensor (DGK) Monitoring System
    This is a multicentre, single arm, prospective, observational clinical study to determine DKA episodes in adult and pediatric people living with type 1 diabetes who will manage their diabetes by use of a Continuous Dual Glucose Ketone (DGK) sensor for 3 months

Primary Outcome Measure

Primary Objective [ Time Frame: 12 months ]

Central Contacts

Find similar trials

Nationwide
Type 1 diabetes trialsEndocrinology trials

Related Studies